mRNA for use in treatment of human genetic diseases
US9061021B2 · kind B2 · utility
35Cited by
35References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2014 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Jul 8, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for modulating the expression of a protein in a target cell comprising at least one RNA molecule which comprises at least one modification conferring stability to the RNA, as well as related methods, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.